Global Pharmaceuticals & Biotech Most Popular Stocks

Bicycle Therapeutics

Market Cap: US$512.9m

A clinical-stage pharmaceutical company, develops a class of medicines for diseases that are underserved by existing therapeutics in the United States and the United Kingdom.

Tibet AIM Pharm

Market Cap: CN¥3.7b

Engages in the research and development, manufacturing, and sale of medical products in China.

Immuneering

Market Cap: US$511.0m

A clinical-stage oncology company, engages in the development of medicines for broad populations of cancer patients.

GlaxoSmithKline Pakistan

Market Cap: PK₨143.7b

Operates as a biopharma company in Pakistan.

Shandong Keyuan Pharmaceutical

Market Cap: CN¥3.6b

Shandong Keyuan Pharmaceutical Co., Ltd. is involved in the research and development, manufacture, and marketing of active pharmaceutical ingredients.

Synmosa Biopharma

Market Cap: NT$15.5b

A specialty pharmaceutical company, researches, develops, manufactures, markets, and distributes pharmaceutical and healthcare products under the Synmosa brand in Taiwan.

Pharmicell

Market Cap: ₩717.0b

A biopharmaceutical company, develops and sells stem cell drugs in South Korea and internationally.

Lexicon Pharmaceuticals

Market Cap: US$508.8m

A biopharmaceutical company, focuses on the discovery, development, and commercialization of pharmaceutical products for the treatment of human disease.

SMO ClinPlusLTD

Market Cap: CN¥3.6b

Provides site management services in research development in pharmaceuticals, medical devices, and health-related products in China.

Prothena

Market Cap: US$506.5m

A late-stage clinical biotechnology company, focuses on discovery and development of novel therapies to treat diseases caused by protein dysregulation in the United States.

Green Cross Holdings

Market Cap: ₩713.3b

Operates as a biotechnology company.

PKU HealthCareLtd

Market Cap: CN¥3.6b

Researches, develops, manufactures, and sells pharmaceutical products in China.

DHG Pharmaceutical

Market Cap: ₫13.3t

Engages in the manufacture and sale of pharmaceutical products in Vietnam.

Boryung

Market Cap: ₩711.3b

Engages in the manufacture and sale of pharmaceutical products in South Korea and internationally.

Shandong Wohua Pharmaceutical

Market Cap: CN¥3.6b

Manufactures and sells pharmaceutical products in China.

YungShin Global Holding

Market Cap: NT$15.3b

Through its subsidiaries, invests in, manufactures, and sells medicines, animal drugs, agricultural chemicals, industrial medicines, and cosmetics.

Jiangxi Synergy Pharmaceutical

Market Cap: CN¥3.6b

Manufactures and sells APIs worldwide.

Dishman Carbogen Amcis

Market Cap: ₹44.1b

Provides contract research and manufacturing services for the pharmaceutical and healthcare industries worldwide.

Hainan Huluwa Pharmaceutical Group

Market Cap: CN¥3.5b

Hainan Huluwa Pharmaceutical Group Co., Ltd.

Shinpoong PharmaceuticalLtd

Market Cap: ₩696.5b

Manufactures and sells pharmaceutical products in South Korea.

Guangdong Hybribio BiotechLtd

Market Cap: CN¥3.5b

Engages in the research and development, manufacture, and sale of nucleic acid molecular diagnostic products for hospitals and medical institutes.

Cloudbreak Pharma

Market Cap: HK$3.8b

A clinical-stage ophthalmology biotechnology company, researches and develops ophthalmic drugs for chronic eye diseases.

Standard BioTools

Market Cap: US$492.8m

Develops, manufactures, and sells a range of instrumentation, consumables, and services to scientists and biomedical researchers to develop therapeutics in the Americas, Europe, the Middle East, Africa, and the Asia pacific.

Yantai Zhenghai Biotechnology

Market Cap: CN¥3.5b

Engages in the research and development, production, and marketing of regenerative medical materials in China.

Zhejiang Haisen Pharmaceutical

Market Cap: CN¥3.5b

Engages in the research and development, production, and sale of chemical active pharmaceutical ingredient and intermediates in China.

Henan Taloph Pharmaceutical StockLtd

Market Cap: CN¥3.5b

Engages in the research, development, and sale of pharmaceutical preparations and Chinese herbal medicines in China.

ScinoPharm Taiwan

Market Cap: NT$14.9b

Research and develops, produces, and sells active pharmaceutical ingredients (API) to pharmaceutical companies in Taiwan, rest of Asia, Europe, India, the United States and internationally.

Gujarat Themis Biosyn

Market Cap: ₹43.4b

Engages in the manufacture of pharmaceuticals and medicinal chemicals in India.

REGENXBIO

Market Cap: US$487.5m

A clinical-stage biotechnology company, provides gene therapies that deliver functional genes to cells with genetic defects in the United States.

Hua Medicine (Shanghai)

Market Cap: HK$3.8b

Engages in the development and commercialization of drugs for the treatment of diabetes in China.

Qingdao Vland Biotech

Market Cap: CN¥3.5b

Engages in the research and development, production, and sale of enzyme preparations, microecological preparations, and animal health products in China and internationally.

Aarti Drugs

Market Cap: ₹42.9b

Through its subsidiaries, manufactures and markets active pharmaceutical ingredients (APIs), pharmaceutical intermediates, specialty chemicals, and formulations in India and internationally.

Shin Nippon Biomedical Laboratories

Market Cap: JP¥72.2b

A contract research organization, engages in the transactional research and medipolis businesses in Japan and internationally.

Sun Pharma Advanced Research

Market Cap: ₹42.8b

A clinical-stage biopharmaceutical company, engages in the research and development of pharmaceutical products in India and internationally.

Opthea

Market Cap: AU$738.8m

A clinical-stage biopharmaceutical company, develops and commercializes drugs for eye diseases in Australia and the United States.

Heartseed

Market Cap: JP¥71.9b

Develops and commercializes iPS cell-derived cardiomyocyte replacement therapy for heart failure.